Cell Reports (Jan 2023)

CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis

  • Shoumin Zhu,
  • Marwah Al-Mathkour,
  • Longlong Cao,
  • Shayan Khalafi,
  • Zheng Chen,
  • Julio Poveda,
  • Dunfa Peng,
  • Heng Lu,
  • Mohammed Soutto,
  • Tianling Hu,
  • Oliver G. McDonald,
  • Alexander Zaika,
  • Wael El-Rifai

Journal volume & issue
Vol. 42, no. 1
p. 112005

Abstract

Read online

Summary: Infection with Helicobacter pylori (H. pylori) is the main risk factor for gastric cancer, a leading cause of cancer-related death worldwide. The oncogenic functions of cyclin-dependent kinase 1 (CDK1) are not fully understood in gastric tumorigenesis. Using public datasets, quantitative real-time PCR, western blot, and immunohistochemical (IHC) analyses, we detect high levels of CDK1 in human and mouse gastric tumors. H. pylori infection induces activation of nuclear factor κB (NF-κB) with a significant increase in CDK1 in in vitro and in vivo models (p < 0.01). We confirm active NF-κB binding sites on the CDK1 promoter sequence. CDK1 phosphorylates and inhibits GSK-3β activity through direct binding with subsequent accumulation and activation of β-catenin. CDK1 silencing or pharmacologic inhibition reverses these effects and impairs tumor organoids and spheroid formation. IHC analysis demonstrates a positive correlation between CDK1 and β-catenin. The results demonstrate a mechanistic link between infection, inflammation, and gastric tumorigenesis where CDK1 plays a critical role.

Keywords